Bryan Stuart - Aug 10, 2021 Form 4 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role
President & Chief Executive Officer, Director
Signature
/s/ Peter Thomson, as attorney-in-fact for Bryan Stuart
Stock symbol
FULC
Transactions as of
Aug 10, 2021
Transactions value $
-$754,600
Form type
4
Date filed
8/12/2021, 04:20 PM
Next filing
Jan 21, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FULC Common Stock Options Exercise $251K +32K $7.84 32K Aug 10, 2021 Direct F1
transaction FULC Common Stock Sale -$560K -32K -100% $17.50 0 Aug 10, 2021 Direct F1
transaction FULC Common Stock Options Exercise $220K +28K $7.84 28K Aug 11, 2021 Direct F1
transaction FULC Common Stock Sale -$665K -28K -100% $23.75* 0 Aug 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FULC Stock Option (right to buy) Options Exercise $0 -32K -10.54% $0.00 272K Aug 10, 2021 Common Stock 32K $7.84 Direct F1, F2
transaction FULC Stock Option (right to buy) Options Exercise $0 -28K -10.31% $0.00 244K Aug 11, 2021 Common Stock 28K $7.84 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
F2 This option was granted on December 18, 2018 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of December 18, 2018. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.

Remarks:

President & Chief Executive Officer